Infections: all 6,701 studies

Page 64 of 68. Open to participants first (800), then studies with results posted, then the rest; newest registration first within each.

• Long-term Follow-up of HIV Infected Patients Identified During Early InfectionCompletedNCT00086372
• KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNCT00085943Phase 3
• Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract InfectionsCompletedNCT00084201Not applicable
• Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIVWithdrawnNCT00084032Not applicable
• A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIVCompletedNCT00082394Phase 4
• Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized SubjectsCompletedNCT00081744Phase 3
• Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired PneumoniaCompletedNCT00081575Phase 3
• Increasing Condom Use in People at Risk for HIV InfectionStatus unknownNCT00080093Not applicable
• Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative OrganismsCompletedNCT00079989Phase 3
• Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00079976Phase 3
• Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
• A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
• Quality of Life in Children With HIV InfectionCompletedNCT00075153
• An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 InfectionCompletedNCT00074997Phase 2
• BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2
• Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and AdolescentsCompletedNCT00073424
• Immune Function of Infants With HIVCompletedNCT00073229
• Study to Evaluate the Effectiveness of StaphVAX in Adults on HemodialysisCompletedNCT00071214Phase 3
• VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious DiseasesCompletedNCT00068926
• A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow TransplantationCompletedNCT00067730Phase 4
• Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00064311Phase 1/2
• Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV InfectionApproved for marketingNCT00062660
• Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal InfectionsCompletedNCT00059878Phase 2
• Safety and Efficacy of BAY 50-4798 in Patients With HIV InfectionCompletedNCT00059462Phase 1/2
• Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)CompletedNCT00058591Phase 1
• Tuberculosis in HIV Infected Patients in UgandaCompletedNCT00057421Phase 2
• Daptomycin for the Treatment of Infections Due to Gram-Positive BacteriaTerminatedNCT00055198Phase 3
• When to Start Anti-HIV Drugs in Patients With Opportunistic InfectionsCompletedNCT00055120Phase 4
• Treatment of Acute HIV Infection to Preserve Immune FunctionCompletedNCT00055094
• Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected PeopleCompletedNCT00052195Phase 2/3
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive PatientsCompletedNCT00050895Phase 3
• Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 InfectionCompletedNCT00050856Phase 3
• Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV InfectionCompletedNCT00050284
• A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced PatientsCompletedNCT00046176Phase 3
• Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00045292Phase 3
• Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal InfectionCompletedNCT00044928Phase 4
• New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsCompletedNCT00044577Phase 3
• Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC InfectionTerminatedNCT00043355Phase 2
• Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.TerminatedNCT00040157Phase 2
• A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV InfectionCompletedNCT00038272Phase 2
• Prevalence of Hepatitis C Virus Infection in HIV-Infected ChildrenCompletedNCT00037076
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
• New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)CompletedNCT00035854Phase 3
• New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)CompletedNCT00035269Phase 3
• PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)CompletedNCT00034671Phase 2
• Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)CompletedNCT00034632Phase 3
• Posaconazole to Treat Invasive Fungal InfectionsCompletedNCT00033982Phase 3
• Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant PatientsTerminatedNCT00031473Phase 3
• Valganciclovir in Congenital CMV InfantsCompletedNCT00031434Phase 1/2
• Neonatal CMV-Ganciclovir Follow-up StudyCompletedNCT00031421
• A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness TrialsCompletedNCT00029913
• Transfusion Infections Pediatric Prospective Study (TRIPPS)CompletedNCT00029406
• Role of Toxins in Lung Infections Caused by Pseudomonas AeruginosaCompletedNCT00027183
• Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant RecipientsCompletedNCT00026767
• Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral LoadCompletedNCT00025922
• Intermittent vs. Continuous HAART to Treat Chronic HIV InfectionCompletedNCT00025909Phase 3
• Tenofovir Disoproxil Fumarate to Treat Pediatric HIVCompletedNCT00024986Phase 1
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily EfavirenzCompletedNCT00023413Phase 2
• Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
• A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex InfectionsCompletedNCT00021567Phase 2
• The Epidemiology of Infection With Vancomycin-Resistant EnterococciCompletedNCT00018434
• Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV DrugsCompletedNCT00017771
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyCompletedNCT00017719Phase 3
• Safety and Tolerability of Z-100 in Patients With Early HIV InfectionTerminatedNCT00016692Phase 1
• Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell TransplantationCompletedNCT00016081Phase 3
• Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell TransplantationCompletedNCT00016068Phase 3
• Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionCompletedNCT00015652Not applicable
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV InfectionCompletedNCT00013520Phase 3
• Kidney Transplant for HIV-Infected Patients in Renal FailureCompletedNCT00009009Phase 2
• Comparing Side Effects of Two Forms of Videx in HIV-Infected AdultsStatus unknownNCT00008489Phase 3
• A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)CompletedNCT00008463Phase 2
• To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI).CompletedNCT00007709
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV PatientsCompletedNCT00007202Phase 2
• Vaccinia Immune Globulin in Treating or Preventing Vaccinal InfectionWithdrawnNCT00006630Phase 1
• Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting MedicationWithdrawnNCT00006578Not applicable
• Capravirine to Treat Children With HIV InfectionCompletedNCT00006519Phase 1
• Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV InfectionCompletedNCT00006443Not applicable
• Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVCompletedNCT00006441Not applicable
• A Test of Behavioral Intervention for Women at High Risk for HIV InfectionCompletedNCT00006440
• A Study of Patients Who Recently Have Been Infected With HIVWithdrawnNCT00006415
• Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their NewbornsCompletedNCT00006396Phase 3
• Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV InfectionWithdrawnNCT00006339Phase 2
• KSHV Infection in Blood Donors From TexasCompletedNCT00006310
• Long-Term Effects of HIV Exposure and Infection in ChildrenCompletedNCT00006304
• Studies of HIV-1 Infection in Newly Infected Individuals in Southern AfricaCompletedNCT00006298
• A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV InfectionCompletedNCT00006154Phase 3
• Effectiveness of Adding Remune to Your Current Anti-HIV Drug CombinationTerminatedNCT00006153Phase 1
• Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIVCompletedNCT00006145Phase 3
• Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 1
• A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsStatus unknownNCT00005663Phase 3
• Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00005590Phase 3
• A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) InfectionCompletedNCT00005572
• Infection and Cardiovascular DiseaseCompletedNCT00005547
• Inflammation, Infection, and Future Cardiovascular RiskCompletedNCT00005496
• Prospective Study of HIV Infection in HemophiliacsCompletedNCT00005309
• Retrovirus Epidemiology Donor Study I (REDS I)CompletedNCT00005278
• Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)CompletedNCT00005274
• Pulmonary Complications of HIV Infection Study (PACS)CompletedNCT00005273
• Observing Patients With Early HIV InfectionCompletedNCT00005020

← Infections overview